Skip to main content
Erschienen in: Supportive Care in Cancer 1/2022

07.08.2021 | Original Article

Implementation and evaluation of a nurse-allied health clinic for patients after haematopoietic stem cell transplantation

verfasst von: Midori Nakagaki, Nicole C. Gavin, Therese Hayes, Rebecca Fichera, Caroline Stewart, Leonie Naumann, Justine Brennan, Natasha Perry, Emma Foley, Erin Crofton, Christie Brown, Jenni Leutenegger, Glen A. Kennedy

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients who undergo haematopoietic stem cell transplantation (HSCT) often have multiple health issues following hospital discharge. In many centres, outpatient follow-up is solely conducted by specialist physicians. We aimed to implement and describe the outcomes of a nurse-allied health multidisciplinary clinic.

Methods

The clinic consisted of six disciplines—nursing, pharmacy, dietetics, physiotherapy, occupational therapy and social work. All allogeneic and high risk autologous HSCT patients were reviewed at 2 weeks after discharge and on day 100 post HSCT, with additional reviews as needed. Occasions of service, interventions, readmission data and physician satisfaction survey were collected prior to and after implementation. Additionally, patient feedback and quality of life survey (FACT-BMT) were collected during the first 6 months.

Results

From July to December 2019, 57 patients were reviewed in the clinic (475 reviews, average 8.3 reviews per patient). Common interventions included the following: exercise programs by physiotherapist (n = 111), diet prescription (n = 103), counselling by social worker (n = 53), medication lists provision (n = 51), fatigue management (n = 43) and nurse education (n = 22). The clinic did not reduce patients’ readmission rate; however, positive feedback from patients and physicians were reported. FACT-BMT results demonstrated that there are unmet needs, particularly fatigue management, sexual education and support, body images, back to work support and quality of life improvement. From discharge to day 100, there was no significant improvement in quality of life.

Conclusions

This clinic provides an innovative approach to patient-centred care in HSCT. It has been well received by patients who were supported by multidisciplinary interventions.
Literatur
2.
Zurück zum Zitat Niederwieser D, Baldomero H, Atsuta Y, Aljurf M, Seber A, Greinix H et al (2019) One and half million hematopoietic stem cell transplants (HSCT). Dissemination, trends and potential to improve activity by telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Blood 134:2035–2035. https://doi.org/10.1182/blood-2019-125232CrossRef Niederwieser D, Baldomero H, Atsuta Y, Aljurf M, Seber A, Greinix H et al (2019) One and half million hematopoietic stem cell transplants (HSCT). Dissemination, trends and potential to improve activity by telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Blood 134:2035–2035. https://​doi.​org/​10.​1182/​blood-2019-125232CrossRef
17.
Zurück zum Zitat Rios M, Suzuki V, Magnum M, Caravia A, Roy J, Zanville N (2020) Implementation of daily multidisciplinary rounds on an adult inpatient blood & marrow transplant unit: initial observations and future plans. Biol Blood Marrow Transplant 26 (3, Supplement):S379-S380. https://doi.org/10.1016/j.bbmt.2019.12.169 Rios M, Suzuki V, Magnum M, Caravia A, Roy J, Zanville N (2020) Implementation of daily multidisciplinary rounds on an adult inpatient blood & marrow transplant unit: initial observations and future plans. Biol Blood Marrow Transplant 26 (3, Supplement):S379-S380. https://​doi.​org/​10.​1016/​j.​bbmt.​2019.​12.​169
19.
Zurück zum Zitat Chieng R, Coutsouvelis J, Poole S, Dooley MJ, Booth D, Wei A (2013) Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic. Support Care Cancer 21(12):3491–3495. https://doi.org/10.1007/s00520-013-1938-9 Chieng R, Coutsouvelis J, Poole S, Dooley MJ, Booth D, Wei A (2013) Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic. Support Care Cancer 21(12):3491–3495. https://​doi.​org/​10.​1007/​s00520-013-1938-9
21.
Metadaten
Titel
Implementation and evaluation of a nurse-allied health clinic for patients after haematopoietic stem cell transplantation
verfasst von
Midori Nakagaki
Nicole C. Gavin
Therese Hayes
Rebecca Fichera
Caroline Stewart
Leonie Naumann
Justine Brennan
Natasha Perry
Emma Foley
Erin Crofton
Christie Brown
Jenni Leutenegger
Glen A. Kennedy
Publikationsdatum
07.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06461-w

Weitere Artikel der Ausgabe 1/2022

Supportive Care in Cancer 1/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.